These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25909088)

  • 1. Progressive decline of glucocerebrosidase in aging and Parkinson's disease.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hallett P; Isacson O
    Ann Clin Transl Neurol; 2015 Apr; 2(4):433-8. PubMed ID: 25909088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
    Rocha EM; Smith GA; Park E; Cao H; Graham AR; Brown E; McLean JR; Hayes MA; Beagan J; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Antioxid Redox Signal; 2015 Aug; 23(6):550-64. PubMed ID: 26094487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.
    Sardi SP; Cheng SH; Shihabuddin LS
    Prog Neurobiol; 2015 Feb; 125():47-62. PubMed ID: 25573151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
    Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
    Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation.
    Delalić S; Rus T; Horvat Ledinek A; Kojović M; Georgiev D
    Clin Park Relat Disord; 2020; 3():100055. PubMed ID: 34316638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.
    van Dijk KD; Persichetti E; Chiasserini D; Eusebi P; Beccari T; Calabresi P; Berendse HW; Parnetti L; van de Berg WD
    Mov Disord; 2013 Jun; 28(6):747-54. PubMed ID: 23712522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.
    Bae EJ; Yang NY; Lee C; Lee HJ; Kim S; Sardi SP; Lee SJ
    Exp Mol Med; 2015 Mar; 47(3):e153. PubMed ID: 25813221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients.
    Papagiannakis N; Xilouri M; Koros C; Stamelou M; Antonelou R; Maniati M; Papadimitriou D; Moraitou M; Michelakakis H; Stefanis L
    Mov Disord; 2015 Nov; 30(13):1830-4. PubMed ID: 26769460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models.
    Sardi SP; Singh P; Cheng SH; Shihabuddin LS; Schlossmacher MG
    Neurodegener Dis; 2012; 10(1-4):195-202. PubMed ID: 22327140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.
    Bourdenx M; Dovero S; Engeln M; Bido S; Bastide MF; Dutheil N; Vollenweider I; Baud L; Piron C; Grouthier V; Boraud T; Porras G; Li Q; Baekelandt V; Scheller D; Michel A; Fernagut PO; Georges F; Courtine G; Bezard E; Dehay B
    Acta Neuropathol Commun; 2015 Jul; 3():46. PubMed ID: 26205255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.
    Di Napoli M; Shah IM; Stewart DA
    Expert Rev Neurother; 2007 Dec; 7(12):1693-729. PubMed ID: 18052765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
    Michel TM; Käsbauer L; Gsell W; Jecel J; Sheldrick AJ; Cortese M; Nickl-Jockschat T; Grünblatt E; Riederer P
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S68-72. PubMed ID: 24262192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.